StockData
Amgen Inc logo

Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen Non-GAAP Operating Income by Year

Non-GAAP Operating Income ($M) ($M)

QuarterlyAnnual

Amgen Non-GAAP Operating Income: $16,203M in FY2025, up 7.8% from a year earlier.

Latest, FY2025
16,203
Period ended Dec 31, 2025
Change on a year earlier
+7.8%
15,028 in FY2024
History
7 years
Since FY2019
Sources
6
Documents cited below

Where the FY2025 figure comes from

“|| Non-GAAP operating income | $ | 4,006 | $ | 4,033 | $ | 16,203 | $ | 15,028”

Source: Form 8-K (amgn-20251231earningsrelea.htm, filed 2026-02-03) ↗

Reported in Form 8-K Reconciliations of GAAP to Non-GAAP Measures.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP Operating Income ($M) ($M)Year on yearSource
FY2025Dec 31, 202516,203+7.8%Form 8-K (amgn-20251231earningsrelea.htm, filed 2026-02-03) ↗
FY2024Dec 31, 202415,028+12.2%Form 8-K (amgn-20241231earningsrelea.htm, filed 2025-02-04) ↗
FY2023Dec 31, 202313,399+5.0%Form 8-K (amgn-20231231earningsrelea.htm, filed 2024-02-06) ↗
FY2022Dec 31, 202212,761+2.7%Form 8-K (amgn-20221231earningsrelea.htm, filed 2023-01-31) ↗
FY2021Dec 31, 202112,424+0.7%Form 8-K (amgenq42021earningsrelease.htm, filed 2022-02-07) ↗
FY2020Dec 31, 202012,334+10.5%Form 8-K (amgn-20201231xq4ex991.htm, filed 2021-02-02) ↗
FY2019Dec 31, 201911,157–Form 8-K (amgn-20201231xq4ex991.htm, filed 2021-02-02) ↗

Breakdown

What makes up non-GAAP Operating Income

Cite this data

StockData. (2026). Amgen Non-GAAP Operating Income ($M), annual FY2019–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/ng-op-inc

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.